TickerFactsScreenerDevelopers

KalVista Pharmaceuticals, Inc. (KALV) — Operating Income

Annual figures by fiscal year, from SEC filings.

2013: -$5.22M2014: -$11.68M2015: -$21.04M2016: -$15.18M2017: -$22.34M2018: -$18.70M2019: -$29.82M2020: -$40.53M2021: -$57.92M2022: -$96.61M2023: -$110.87M2024: -$140.44M2025: -$188.00M-$188.00M
2013Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$188.00M-33.9%
2024-$140.44M-26.7%
2023-$110.87M-14.8%
2022-$96.61M-66.8%
2021-$57.92M-42.9%
2020-$40.53M-35.9%
2019-$29.82M-59.4%
2018-$18.70M+16.3%
2017-$22.34M-47.2%
2016-$15.18M+27.8%
2015-$21.04M-80.1%
2014-$11.68M-123.9%
2013-$5.22M—